Volume 34, Issue 7 (October 2023)
Studies in Medical Sciences 2023, 34(7): 417-426 |
Back to browse issues page
Research code: IR.UMSU.REC.1399.352
Ethics code: IR.UMSU.REC.1399.352
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Khezri R, Rezaei F, Jahanian S, Ebrahimi K. Severe COVID-19 and Its Related Factors in Pregnant Women: A Multi-Center Cross‐Sectional Study. Studies in Medical Sciences 2023; 34 (7) :417-426
URL: http://umj.umsu.ac.ir/article-1-6025-en.html
URL: http://umj.umsu.ac.ir/article-1-6025-en.html
Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti Uneversity of Medical Sciences, Tehran, Iran (Corresponding Author) , kamran.ebrahimi4377@gmail.com
Abstract: (1424 Views)
Background & Aims: Pregnant women are at a higher risk of contracting COVID-19 due to their weakened immune systems. There are various related factors for severe COVID-19 in pregnant women. This study aimed to assess the severe COVID-19 rate and its associated factors among Iranian pregnant women.
Materials & Methods: In this multi-center cross-sectional study from 21 March 2020-21 March 2021, all pregnant women (N=488) with COVID-19 who were admitted to healthcare centers in three counties (Mahabad, Miandoab, Bukan) in Iran were enrolled. Patients were categorized into two groups; hospitalized (severe COVID-19) and non-hospitalized. Data were collected through medical records using a researcher-made questionnaire. Statistical analysis was performed using multivariate logistic regression.
Results: The mean age of pregnant women was 29.8±6.37 years and 19.9% were hospitalized(N=89). The COVID-19 hospitalization in pregnant women was significantly associated with fever (temperature ≥38 C) [aOR = 3.59, (95%CI; 2.08-6.17)], shortness of breath [aOR = 2.12, (95%CI; 1.24-3.61)], diagnosis of COVID-19 in the second trimester [aOR = 4.48, 95%CI; 1.48-13.58)], residence in the urban area [aOR = 0.45, (95%CI; 0.24-0.84)], and diploma and more education level [aOR = 0.58, (95%CI; 0.33-0.98)].
Conclusion: Urban residency and higher education level were protective factors. Fever, shortness of breath, and diagnosis of COVID-19 in the second trimester of pregnancy were related factors for hospitalization. Early diagnostic and therapeutic interventions for pregnant women with positive COVID-19 tests are essential in disease control. a longitudinal study with appropriate follow-up time to identify factors related to severe COVID-19 among pregnant women is needed.
Materials & Methods: In this multi-center cross-sectional study from 21 March 2020-21 March 2021, all pregnant women (N=488) with COVID-19 who were admitted to healthcare centers in three counties (Mahabad, Miandoab, Bukan) in Iran were enrolled. Patients were categorized into two groups; hospitalized (severe COVID-19) and non-hospitalized. Data were collected through medical records using a researcher-made questionnaire. Statistical analysis was performed using multivariate logistic regression.
Results: The mean age of pregnant women was 29.8±6.37 years and 19.9% were hospitalized(N=89). The COVID-19 hospitalization in pregnant women was significantly associated with fever (temperature ≥38 C) [aOR = 3.59, (95%CI; 2.08-6.17)], shortness of breath [aOR = 2.12, (95%CI; 1.24-3.61)], diagnosis of COVID-19 in the second trimester [aOR = 4.48, 95%CI; 1.48-13.58)], residence in the urban area [aOR = 0.45, (95%CI; 0.24-0.84)], and diploma and more education level [aOR = 0.58, (95%CI; 0.33-0.98)].
Conclusion: Urban residency and higher education level were protective factors. Fever, shortness of breath, and diagnosis of COVID-19 in the second trimester of pregnancy were related factors for hospitalization. Early diagnostic and therapeutic interventions for pregnant women with positive COVID-19 tests are essential in disease control. a longitudinal study with appropriate follow-up time to identify factors related to severe COVID-19 among pregnant women is needed.
Type of Study: Research |
Subject:
زنان و زایمان
References
1. Khezri R, Rezaei F, Motevalli FD. Covid-19 pandemic and risk of Myopia. Ann Med Surg 2022;79. [DOI:10.1016/j.amsu.2022.103944] [PMID] [PMCID]
2. Azarbakhsh H, Jokari K, Moftakhar L, Ghojogh MG, Karimyan A, Salmanzadeh S, et al. Epidemiological characteristics of patients with COVID-19 in Southwest of Iran from February 19 to June 20, 2020. Med J Islam Repub Iran 2021;35:116. [DOI:10.47176/mjiri.35.116] [PMID] [PMCID]
3. Khezri R, Valizadeh R, Nozad P, Maleki Z, Ghelichi-Ghojogh M. Demand for Psychiatrist Nurse in the COVID-19 Inpatient Wards. J Health Sci Surveill Syst 2022;10(2):233-4. [Google Scholar]
4. Behram M, Oğlak SC, Doğan Y. Evaluation of BRD4 levels in patients with early-onset preeclampsia. J Gynecol Obstet Hum Reprod 2021;50(2):101963. [DOI:10.1016/j.jogoh.2020.101963] [PMID]
5. Silasi M, Cardenas I, Kwon JY, Racicot K, Aldo P, Mor G. Viral infections during pregnancy. Am J Reprod Immunol 2015;73(3):199-213. [DOI:10.1111/aji.12355] [PMID] [PMCID]
6. Khezri R, Shojaie L, Nikbakht H-A, Jahanian S, Ghelichi-Ghojogh M. Coronavirus pandemic and pregnant mothers. Ann Med Surg 2022. [DOI:10.1016/j.amsu.2022.104376] [PMID] [PMCID]
7. LoMauro A, Aliverti A. Respiratory physiology of pregnancy: physiology masterclass. Breathe 2015;11(4):297-301. [DOI:10.1183/20734735.008615] [PMID] [PMCID]
8. Vale AJM, Fernandes ACL, Guzen FP, Pinheiro FI, de Azevedo EP, Cobucci RN. Susceptibility to COVID-19 in pregnancy, labor, and postpartum period: immune system, vertical transmission, and breastfeeding. Front. Glob. Womens Health 2021;2:602572. [DOI:10.3389/fgwh.2021.602572] [PMID] [PMCID]
9. Lam CM, Wong SF, Leung TN, Chow KM, Yu WC, Wong TY, et al. A case‐controlled study comparing clinical course and outcomes of pregnant and non‐pregnant women with severe acute respiratory syndrome. BJOG 2004;111(8):771-4. [DOI:10.1111/j.1471-0528.2004.00199.x] [PMID] [PMCID]
10. Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(2):100107. [DOI:10.1016/j.ajogmf.2020.100107] [PMID] [PMCID]
11. Pregnancy. C-a. Centers for Disease Control and Prevention. [cited 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/pregnant-people.html. [URL]
12. Khezri R, Salarilak S, Jahanian S. The association between maternal anemia during pregnancy and preterm birth. Clin Nutr ESPEN 2023;56:13-7. [DOI:10.1016/j.clnesp.2023.05.003] [PMID]
13. Sekkarie PA, Woodruff PR, Whitaker M, Kramer M, Zapata L, Ellington S, et al. Characteristics and treatment of hospitalized pregnant women with Coronavirus Disease 2019, COVID-19 (preprint). 2022. [DOI:10.21203/rs.3.rs-1522990/v1]
14. Vouga M, Favre G, Martinez-Perez O, Pomar L, Acebal LF, Abascal-Saiz A, et al. Maternal outcomes and risk factors for COVID-19 severity among pregnant women. Sci Rep 2021;11(1):1-11. [DOI:10.1038/s41598-021-92357-y] [PMID] [PMCID]
15. Celewicz A, Celewicz M, Michalczyk M, Woźniakowska-Gondek P, Krejczy K, Misiek M, et al. Pregnancy as a risk factor of severe COVID-19. J Clin Med 2021;10(22):5458. [DOI:10.3390/jcm10225458] [PMID] [PMCID]
16. Menezes MO, Takemoto ML, Nakamura‐Pereira M, Katz L, Amorim MM, Salgado HO, et al. Risk factors for adverse outcomes among pregnant and postpartum women with acute respiratory distress syndrome due to COVID‐19 in Brazil. Int J Gynaecol Obstet 2020;151(3):415-23. [DOI:10.1002/ijgo.13407] [PMID] [PMCID]
17. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. Br Med J 2020;370. [DOI:10.1097/01.aoa.0000744128.44930.48]
18. Rezaei F, Ghelichi-Ghojogh M, Hemmati A, Ghaem H, Mirahmadizadeh A. Risk factors for COVID-19 severity and mortality among inpatients in Southern Iran. J Prev Med Hyg 2021;62(4):E808. [PMID]
19. Barbero P, Mugüerza L, Herraiz I, Garcia Burguillo A, San Juan R, Forcén L, et al. SARS-CoV-2 in pregnancy: characteristics and outcomes of hospitalized and non-hospitalized women due to COVID-19. J Matern-Fetal Neonatal Med 2022;35(14):2648-54. [DOI:10.1080/14767058.2020.1793320] [PMID]
20. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020;395(10226):809-15.
https://doi.org/10.1016/S0140-6736(20)30360-3 [DOI:10.1016/s0140-6736(20)30360-3] [PMID]
21. Khan MMA, Khan MN, Mustagir MG, Rana J, Haque MR, Rahman MM. COVID-19 infection during pregnancy: a systematic review to summarize possible symptoms, treatments, and pregnancy outcomes. MedRxiv 2020. [DOI:10.1101/2020.03.31.20049304]
22. Sattari M, Bashirian S, Masoumi SZ, Shayan A, Jenabi E, Ghelichkhani S, et al. Evaluating Clinical Course and risk factors of Infection and demographic characteristics of pregnant women with COVID-19 in Hamadan Province, West of Iran. J Health Sci Res 2020;20(3):e00488. [DOI:10.34172/jrhs.2020.22] [PMID] [PMCID]
23. Tutiya C, Mello F, Chaccur G, Almeida C, Galvao E, Barbosa de Souza AC, et al. Risk factors for severe and critical Covid-19 in pregnant women in a single center in Brazil. J Matern-Fetal Neonatal Med 2021:1-4. [DOI:10.1080/14767058.2021.1880561] [PMID]
24. Sahin D, Tanacan A, Erol SA, Yucel Yetiskin FD, Besimoglu B, Ozden Tokalioglu E, et al. Management of pregnant women with COVID‐19: A tertiary pandemic center experience on 1416 cases. J Med Virol 2022;94(3):1074-84. [DOI:10.1002/jmv.27423] [PMID] [PMCID]
25. Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, et al. Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clin Infect Dis 2021;73(2):328-31. [DOI:10.1093/cid/ciaa1150] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
